CAMBRIDGE, MA: Results Show a Significant Increase in Dystrophin Production and a Stabilization of Walking Ability in Duchenne Muscular Dystrophy Patients
...
CAMBRIDGE, MA: Submission of New Drug Application for Eteplirsen Planned for First Half of 2014; Preparations for Confirmatory Eteplirsen Study and Manufacturing Scale Up Remain on Track; Well Capitalized With $164. ...
WINNIPEG, MANITOBA: Vancouver Firm to Enhance Market Communications of Miraculins Advances Including its Acquisition of the SCOUT DS(R) Non-Invasive Diabetes Testing Technology
...
HALIFAX, NOVA SCOTIA: Support from Province of Nova Scotia Offers Validation of IMV Clinical Programs; Ensures Funding Available for Additional Clinical Development in Coming Years
...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.